PlainRecalls
FDA Drug Critical Class I Terminated

Euphoric Premium Male Performance Enhancer capsules, packaged in a)1-count blister cards, UPC 6 96859 28646 9, b) 3-count bottle, UPC 6 96859 28647 6 and c) 12-count bottle, UPC 6 96859 28648 3.

Reported: November 21, 2018 Initiated: April 16, 2018 #D-0288-2019

Product Description

Euphoric Premium Male Performance Enhancer capsules, packaged in a)1-count blister cards, UPC 6 96859 28646 9, b) 3-count bottle, UPC 6 96859 28647 6 and c) 12-count bottle, UPC 6 96859 28648 3.

Reason for Recall

Marketed Without An Approved NDA/ANDA: product contains undeclared sildenafil, tadalafil, and oxytetracycline, FDA approved drug products making Euphoric an unapproved drug.

Details

Recalling Firm
Epic Products, LLC
Units Affected
a) 106,329 cards; b) 109,725 bottles; c) 28,644 bottles
Distribution
Nationwide in the USA
Location
Overland Park, KS

Frequently Asked Questions

What product was recalled?
Euphoric Premium Male Performance Enhancer capsules, packaged in a)1-count blister cards, UPC 6 96859 28646 9, b) 3-count bottle, UPC 6 96859 28647 6 and c) 12-count bottle, UPC 6 96859 28648 3.. Recalled by Epic Products, LLC. Units affected: a) 106,329 cards; b) 109,725 bottles; c) 28,644 bottles.
Why was this product recalled?
Marketed Without An Approved NDA/ANDA: product contains undeclared sildenafil, tadalafil, and oxytetracycline, FDA approved drug products making Euphoric an unapproved drug.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 21, 2018. Severity: Critical. Recall number: D-0288-2019.